Eli Lilly Net Working Capital Over Time
| LLY Stock | USD 749.92 3.49 0.46% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Eli Lilly Performance and Eli Lilly Correlation. Eli |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.682 | Dividend Share 5.03 | Earnings Share 9.27 | Revenue Per Share 45.368 | Quarterly Revenue Growth 0.204 |
The market value of Eli Lilly is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Working Capital Analysis
Compare Eli Lilly and related stocks such as Merck Company, Pfizer Inc, and Eshallgo Class A Net Working Capital Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 3.7 B | 5.3 B | 437 M | 6.4 B | 11.5 B | 6.5 B | 6.3 B |
| PFE | 10.7 B | 10.7 B | 10.7 B | 10.7 B | 10.7 B | 10.7 B | 10.7 B | 10.7 B | 18.1 B | (4.5 B) | 9.1 B | 17 B | 9.1 B | (4.5 B) | (4.2 B) |
| EHGO | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 9.8 M | 13.8 M | 14.5 M | 15.7 M | 13.3 M |
| ASYS | 71.1 M | 71.1 M | 71.1 M | 71.1 M | 71.1 M | 71.1 M | 71.1 M | 79.1 M | 77.6 M | 69.1 M | 65.8 M | 80.3 M | 51.5 M | 46.3 M | 56.5 M |
| GFI | 260.4 M | 260.4 M | 260.4 M | 260.4 M | 260.4 M | 260.4 M | 260.4 M | 260.4 M | 305.6 M | (266.7 M) | 843.3 M | 598.7 M | 1 B | 381.9 M | 493.5 M |
| LPG | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 3.2 M | 54.6 M | 71.3 M | 213.1 M | 141.7 M | 267.1 M | 280.4 M |
| FORM | 213.7 M | 213.7 M | 213.7 M | 213.7 M | 213.7 M | 213.7 M | 213.7 M | 213.7 M | 235.3 M | 282.5 M | 332.5 M | 375.3 M | 324.9 M | 442.7 M | 346.8 M |
| CNK | 188.7 M | 188.7 M | 188.7 M | 188.7 M | 188.7 M | 188.7 M | 188.7 M | 188.7 M | 84.3 M | (73.8 M) | 286.3 M | 105.3 M | 155.1 M | 329.7 M | 169 M |
Eli Lilly and related stocks such as Merck Company, Pfizer Inc, and Eshallgo Class A Net Working Capital description
My Equities
My Current Equities and Potential Positions
| Eli Lilly and | LLY |
| Classification | Healthcare |
| Location | Indiana; U.S.A |
| Exchange | New York Stock Exchange |
USD 749.92
Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.